局部区域肿瘤复发的临床试验
总计108682个结果
-
AstraZeneca完全的
-
Eli Lilly and CompanyNational Cancer Institute (NCI)完全的
-
Ulrik LassenUniversity of Copenhagen; Boehringer Ingelheim完全的
-
University of Zurich完全的
-
Abramson Cancer Center of the University of Pennsylvania完全的
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma Institute招聘中
-
University of WashingtonNational Cancer Institute (NCI); United States Department of Defense招聘中
-
University of WashingtonNational Cancer Institute (NCI); Merck Sharp & Dohme LLC完全的
-
GOG FoundationNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)NRG Oncology完全的
-
National Cancer Institute (NCI)NRG Oncology完全的
-
Universitair Ziekenhuis Brussel尚未招聘
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; InSightec尚未招聘
-
Nicholas ButowskiNational Cancer Institute (NCI); Revolution Medicines, Inc.招聘中
-
L. Nicolas Gonzalez Castro, MD, PhDMerck Sharp & Dohme LLC招聘中
-
Xuanwu Hospital, BeijingBeijing Neoantigen Biotechnology Company招聘中
-
Emory UniversityNational Cancer Institute (NCI)招聘中
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Oncovir, Inc.; Phase One Foundation招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer InstituteVascular Biogenics Ltd. operating as VBL Therapeutics主动,不招人
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Peloton Therapeutics, Inc.完全的
-
Baptist Health South FloridaBristol-Myers Squibb; NovoCure Ltd.终止
-
Prof. Dr. Berthold SchalkeCrolll Gmbh完全的
-
Hebei Yanda HospitalBeijing Tiantan Hospital未知
-
INSYS Therapeutics IncPediatric Brain Tumor Consortium (PBTC), St. Jude Children's Research Hospital撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中